Effect of chlorogenic acid on disordered glucose and lipid metabolism in db/db mice and its mechanism

Acta Academiae Medicinae Sinicae

Volumn 33, Issue 3, 2011, Pages 281-286

  Zhang, Lan Tao ^a   Chang, Cui Qing ^a   Liu, Yang ^a   Chen, Zhi Min ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

Adiponectin; Chlorogenic acid; db db mice; Glucose lipid metabolism; Visfatin

Indexed keywords

ADIPONECTIN; CHLOROGENIC ACID; GLUCOSE; GLUCOSE 6 PHOSPHATASE; LIPID; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONTROLLED STUDY; DRUG EFFECT; GLUCOSE METABOLISM; INTRAABDOMINAL FAT; LIPID METABOLISM; LIVER; MALE; METABOLIC DISORDER; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVIEW;

ADIPONECTIN; ANIMALS; CHLOROGENIC ACID; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSE; GLUCOSE-6-PHOSPHATASE; LIPID METABOLISM; LIVER; MALE; MICE; PPAR ALPHA;

EID: 79960895891     PISSN: 1000503X     EISSN: None     Source Type: Journal    
DOI: 10.3881/j.issn.1000-503X.2011.03.015     Document Type: Review

References (14)

1. van Dijk AE, Olthof MR, Meeuse JC, et al. Acute effects of decaffeinated coffee and the major coffee components chlorogenic acid and trigonelline on glucose tolerance [J]. Diabetes Care, 2009, 32(6):1023-1025.
2. Karthikesan K, Pari L, Menon VP. Combined treatment of tetrahydrocurcumin and chlorogenic acid exerts potential antihyperglycemic effect on streptozotocin-nicotinamide-induced diabetic rats [J]. Gen Physiol Biophys, 2010, 29(1):23-30.
3. Karthikesan K, Pari L, Menon VP. Antihyperlipidemic effect of chlorogenic acid and tetrahydrocurcumin in rats subjected to diabetogenic agents [J]. Chem Biol Interact, 2010, 188 (3):643-650.
4. Li SY, Chang CQ, Ma FY, et al. Modulating effects of chlorogenic acid on lipids and glucose metabolism and expression of hepatic peroxisome proliferator-activated receptor-alpha in golden hamsters fed on high fat diet [J]. Biomed Environ Sci, 2009, 22(2):122-129.
5. Savage DB, Petersen KF, Shulman GI. Disordered lipid metabolism and the pathogenesis of insulin resistance [J]. Physiol Rev, 2007, 87(2):507-520.
6. Arion WJ, Canfield WK, Ramos FC, et al. Chlorogenic acid and hydroxynitrobenzaldehyde: new inhibitors of hepatic glucose 6-phosphatase [J]. Arch Biochem Biophys, 1997, 339(2):315-322.
7. Antuna-Puente B, Feve B, Fellahi S, et al. Adipokines: the missing link between insulin resistance and obesity [J]. Diabetes Metab, 2008, 34(1):2-11.
8. Chen X, Matthews J, Zhou L, et al. Improvement of dyslipidemia, insulin sensitivity, and energy balance by a peroxisome proliferator-activated receptor alpha agonist [J]. Metabolism, 2008, 57(11):1516-1525.
9. Yamauchi T, Hara K, Kubota N, et al. Dual roles of adiponectin/Acrp30 in vivo as an anti-diabetic and anti-atherogenic adipokine [J]. Curr Drug Targets Immune Endocr Metabol Disord, 2003, 3(4):243-254.
10. Cho AS, Jeon SM, Kim MJ, et al. Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in high-fat diet-induced-obese mice [J]. Food Chem Toxicol, 2010, 48(3):937-943.
11. Yamauchi T, Kadowaki T. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases [J]. Int J Obes (Lond), 2008, 32 Suppl 7:S13-S18.
12. Berndt J, Klöting N, Kralisch S, et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans [J]. Diabetes, 2005, 54(10):2911-2916.